ArticleJournal of diabetes and metabolic disorders2025
Prevalence and determinants of metabolic syndrome among Tehran adults: a cross-sectional analysis from the Tehran cohort study (TeCS).
Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevalence of Coronary Artery Diseases Among Adult Women Residents of Tehran: A Cross-Sectional Report From Tehran Cohort Study (TeCS).Cardiology research and practice · 2026Article
- Sex Differences in the Prevalence and Associated Factors of Metabolic Syndrome: A Cross-Sectional Study of University Employees in China.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metabolic syndrome (MetS) is a cluster of risk factors that increase the risk of cardiovascular disease and type 2 diabetes. We aim to investigate the prevalence of MetS based on four prevalent criteria and its associated factors among Tehran's adult residents. Methods: We utilized the data from the enrollment phase of the Tehran Cohort Study (TeCS). We included the demographic, anthropometric, and biomedical data of 8,232 adult Tehran residents. MetS was defined using four criteria: World Health Organization (WHO), Adult Treatment Panel III (ATP III), International Diabetes Federation (IDF), and Joint Interim Statement (JIS). Sex and age-adjusted prevalence estimates and associated factors were analyzed using regression models. Results: The Participants' mean age was 53.7 ± 12.72 years, and 54% were women. The sex and age-adjusted prevalence of MetS varied depending on the diagnostic criteria used, with the highest rates reported using the JIS criteria (59.3%), followed by the IDF criteria (46.8%), ATP-III (27.1%), and WHO criteria (11.0%). The prevalence generally increased with age across all criteria in both females and males. Females had a higher prevalence than males, except for the WHO and JIS criteria. Factors associated with higher odds of MetS included older age, female gender, lower education level, and low physical activity level. Tobacco use and opium use were associated with lower odds of MetS based on IDF and JIS criteria. Conclusion: MetS is highly prevalent among Tehran adults, with notable variation based on diagnostic criteria. Preventive efforts should address modifiable lifestyle factors. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-025-01708-3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.